Aetion Revenue and Competitors
Estimated Revenue & Valuation
- Aetion's estimated annual revenue is currently $58.7M per year.
- Aetion received $27.0M in venture funding in February 2019.
- Aetion's estimated revenue per employee is $177,800
- Aetion's total funding is $203.6M.
Employee Data
- Aetion has 330 Employees.
- Aetion grew their employee count by -16% last year.
Aetion's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder and President | Reveal Email/Phone |
2 | Co-Founder and Advisor | Reveal Email/Phone |
3 | Chief Staff, Office the CEO | Reveal Email/Phone |
4 | VP | Reveal Email/Phone |
5 | Chief Staff, Office the President | Reveal Email/Phone |
6 | VP, North America Growth | Reveal Email/Phone |
7 | VP, Delivery & Data Operations | Reveal Email/Phone |
8 | VP Engineering | Reveal Email/Phone |
9 | VP Global Scientific Data Insights | Reveal Email/Phone |
10 | VP Science/Sr. Scientist at Aetion | Reveal Email/Phone |
Aetion Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $27.2M | 181 | -36% | $162.2M | N/A |
#2 | $3.8M | 34 | 0% | N/A | N/A |
#3 | $60.8M | 342 | 12% | $800M | N/A |
#4 | $3.6M | 32 | -6% | N/A | N/A |
#5 | $53.7M | 302 | -16% | $26.9M | N/A |
#6 | $2.8M | 29 | -31% | N/A | N/A |
#7 | $197M | 1454 | -5% | $112.6M | N/A |
#8 | $22.6M | 150 | -8% | $45M | N/A |
#9 | $21.6M | 0 | N/A | $13.2M | N/A |
#10 | $4070M | 4114 | -6% | $1.9B | N/A |
What Is Aetion?
Aetion offers the world's most advanced and fastest growing real-world evidence platform, accelerating the development and impact of treatments. With its patented rapid-cycle analytics technology, the Aetion platform uses the everyday clinical and financial interactions of health care to unlock essential evidence about treatment effectiveness and value. Founded by Harvard Medical School faculty members and a pioneer in big data, Aetion helps biopharma and payers and, most importantly, patients thrive in the era of value-based care. Visit aetion.com and learn how Aetion, together with its biopharma and payer customers, is advancing the global adoption of real-world evidence for critical health care decisions.
keywords:Healthcare,Pharmaceuticals, saas$203.6M
Total Funding
330
Number of Employees
$58.7M
Revenue (est)
-16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aetion News
Aetion, real-world evidence (RWE) tech and analytics provider, and Cognito Therapeutics, a pioneer in neuromodulation therapeutics for...
D., M.P.H., from Aetion Inc. in New York City, and colleagues examined the association between receipt of Ad26.COV2.S vaccine and COVID-19-...
NEW YORK, Sept. 14, 2021 /PRNewswire/ -- Aetion, a leading health technology company, announces that Marla Kessler will become its first Chief Customer Officer. Kessler will lead Aetion's efforts to create superior customer experiences, oversee marketing and communications teams, and support t ...
Thanks to a 2020 spent proving the usefulness of its real-world evidence platform in rapidly responding to a global health crisis, Aetion has more than doubled its total venture funding to date with the close of a $110 million series C. RELATED: FDA, Aetion dive into the real-world data surroun ...
BOSTON and NEW YORK, May 11, 2021 /PRNewswire/ -- Health care technology company Aetion announced today a $110 million Series C fundraise, led by Warburg Pincus, a leading global growth equity firm, with additional investments from B Capital and Foresite Capital. Aetion's existing backers New En ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $103.1M | 330 | 18% | N/A |
#2 | $96.5M | 330 | 8% | N/A |
#3 | $111.4M | 330 | 1% | N/A |
#4 | $54.5M | 330 | 0% | N/A |
#5 | $96.5M | 330 | 5% | N/A |
Aetion Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2017-03-21 | $11.2M | A | Flare Capital Partners | Article |
2018-04-12 | $36.0M | B | New Enterprise Associates (NEA) | Article |
2019-02-06 | $27.0M | Undisclosed | MULTIPLE | Article |